奈米醫材

+2.10 (+3.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

72.1082成交張數36.60本益比1.79股價淨值比1.82%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	32	19	37.7%	2.06	39.89	5.3%	3.0%	0.5	0.5
2026Q1	32	19	37.5%	2.07	39.54	2.4%	1.3%	-0.1	-0.2
2025Q4	32	18	38.1%	2.04	38.62	2.9%	1.7%	-0.0	-0.1
2025Q3	31	18	39.9%	1.94	36.94	3.8%	2.1%	-0.8	-0.9
2025Q2	30	16	41.9%	1.90	37.13	5.8%	3.3%	1.1	1.1
2025Q1	31	17	41.4%	2.22	39.94	7.6%	5.0%	-0.9	-1.0
2024Q4	30	17	41.4%	2.46	38.54	6.4%	4.2%	0.9	0.8
2024Q3	29	16	41.8%	2.56	36.62	5.1%	3.0%	-0.4	-0.8
2024Q2	28	17	36.1%	2.56	42.42	5.4%	3.5%	-0.7	-0.7
2024Q1	20	16	14.6%	8.46	41.45	7.6%	6.0%	0.1	-0.0
2023Q4	19	16	12.6%	10.45	40.29	8.0%	6.6%	0.1	0.2
2023Q3	15	10	26.6%	3.28	29.38	13.6%	9.7%	-0.7	-0.7
2023Q2	12	9	18.9%	5.86	27.02	16.2%	12.5%	0.1	-0.4
2023Q1	11	9	17.6%	4.48	25.50	15.5%	11.8%	0.3	0.2
2022Q4	10	9	10.1%	7.11	25.72	15.9%	12.8%	0.1	0.1
2022Q3	11	9	16.3%	4.04	25.38	16.7%	12.8%	0.5	0.4
2022Q2	10	8	16.2%	3.87	23.09	13.7%	10.6%	0.6	0.5
2022Q1	10	8	17.5%	3.81	22.12	11.5%	8.8%	0.1	0.1
2021Q4	10	7	15.0%	4.81	21.98	8.3%	6.5%	0.2	0.2
2021Q3	9	7	16.3%	4.28	20.83	4.7%	3.6%	-0.2	-0.2
2021Q2	9	7	19.4%	5.43	20.15	5.5%	4.4%	0.1	0.1
2021Q1	9	7	19.1%	5.31	19.91	5.3%	4.2%	0.2	0.2
2020Q4	8	7	17.2%	6.67	19.74	8.1%	6.3%	0.0	0.0
2020Q3	8	7	17.5%	5.74	19.35	11.1%	8.6%	0.2	0.2
2020Q2	8	6	14.0%	6.79	18.74	12.1%	9.3%	0.2	0.2
2020Q1	8	6	14.3%	6.61	18.63	16.1%	12.3%	0.2	0.2
2019Q4	8	6	17.5%	4.94	18.48	13.6%	11.5%	0.3	0.2
2019Q3	8	6	18.3%	4.64	18.51	11.8%	9.8%	0.4	-0.2
2019Q2	8	6	20.8%	4.38	17.76	–	–	0.1	0.0
2019Q1	8	6	26.7%	3.14	17.25	–	–	0.1	-0.1
2018Q4	6	6	7.4%	19.30	17.16	–	–	-0.1	-0.2
2018Q3	6	6	9.0%	15.49	17.09	–	–	–	–